Bausch Health Companies Inc.
Bausch Health Companies Inc.
Insider Sentiment (TTM):
Last Purchase:2025-11-25Last Sale:2026-05-19Shares Purchased (TTM):37,307,527Shares Sold (TTM):66,546
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:226,741,488Shares Outstanding:372,800,000Institutional Ownership Pct.:60.82%
Earnings Market Reaction:
Filing Date:2026-04-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1,299 | 1,309 | 1,308 | 1,727 | 1,134 | 1,181 | 719 | 595 | 733 | 947 | 760 | 579 | |||||
Restricted Cash Current | 13 | 16 | 32 | 16 | 23 | 20 | 31 | 28 | 22 | 15 | 20 | 9 | |||||
Receivables Net Current | 2,191 | 2,351 | 2,417 | 2,210 | 2,072 | 2,140 | 2,094 | 2,102 | 2,048 | 1,998 | 1,948 | 1,743 | |||||
Inventory Net | 1,601 | 1,629 | 1,598 | 1,655 | 1,613 | 1,595 | 1,655 | 1,612 | 1,636 | 1,544 | 1,272 | 1,240 | |||||
Prepaid Expense And Other Assets Current | 874 | 852 | 894 | 906 | 890 | 838 | 852 | 874 | 957 | 1,092 | 1,048 | 890 | |||||
Assets Current | 5,978 | 6,157 | 6,249 | 6,514 | 5,732 | 5,774 | 5,351 | 5,211 | 5,396 | 5,596 | 5,048 | 4,461 | |||||
Property Plant And Equipment And Finance Lease Rig… | 2,095 | 2,074 | 2,026 | 1,994 | 1,882 | 1,780 | 1,789 | 1,738 | 1,713 | 1,707 | 1,584 | 1,599 | |||||
Intangible Assets Net Excluding Goodwill | 4,404 | 4,643 | 4,830 | 5,047 | 5,297 | 5,551 | 5,652 | 5,903 | 6,183 | 6,456 | 6,728 | 5,299 | |||||
Goodwill | 9,807 | 11,271 | 11,287 | 11,298 | 11,153 | 11,087 | 11,171 | 11,127 | 11,160 | 11,183 | 11,187 | 11,628 | |||||
Deferred Income Tax Assets Net | 1,845 | 1,843 | 2,050 | 2,025 | 1,977 | 1,968 | 2,188 | 2,187 | 2,149 | 2,101 | 2,189 | 2,191 | |||||
Other Assets Noncurrent | 369 | 378 | 382 | 388 | 380 | 363 | 389 | 329 | 312 | 307 | 328 | 325 | |||||
Assets | 24,498 | 26,366 | 26,824 | 27,266 | 26,421 | 26,523 | 26,540 | 26,495 | 26,913 | 27,350 | 27,064 | 25,503 | |||||
Liabilities | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 593 | 600 | 616 | 627 | 620 | 589 | 667 | 579 | 642 | 719 | 569 | 515 | |||||
Accrued Liabilities Current | 3,037 | 3,344 | 3,598 | 3,469 | 3,354 | 3,489 | 3,386 | 3,338 | 3,225 | 3,133 | 3,119 | 3,008 | |||||
Long Term Debt Current | 889 | 225 | 579 | 879 | 282 | 2,674 | 453 | 452 | 538 | 450 | 536 | 444 | |||||
Liabilities Current | 4,530 | 4,180 | 4,793 | 4,975 | 4,256 | 6,752 | 4,506 | 4,369 | 4,405 | 4,302 | 4,224 | 3,967 | |||||
Long Term Debt Noncurrent | 19,875 | 20,592 | 20,463 | 20,859 | 21,228 | 18,942 | 21,054 | 21,208 | 21,536 | 21,938 | 21,894 | 20,108 | |||||
Deferred Income Tax Liabilities Net | 179 | 147 | 145 | 144 | 134 | 128 | 169 | 170 | 170 | 163 | 213 | 215 | |||||
Other Liabilities Noncurrent | 763 | 793 | 843 | 877 | 761 | 713 | 805 | 745 | 751 | 776 | 721 | 745 | |||||
Liabilities | 25,580 | 25,989 | 26,468 | 27,119 | 26,661 | 26,845 | 26,782 | 26,722 | 27,087 | 27,432 | 27,299 | 25,232 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 10,542 | 10,516 | 10,515 | 10,510 | 10,508 | 10,490 | 10,489 | 10,483 | 10,480 | 10,423 | 10,420 | 10,412 | |||||
Additional Paid In Capital Common Stock | 295 | 357 | 275 | 250 | 220 | 234 | 201 | 181 | 164 | 214 | 190 | 188 | |||||
Retained Earnings Accumulated Deficit | -11,090 | -9,667 | -9,555 | -9,734 | -9,882 | -9,824 | -9,917 | -9,832 | -9,842 | -9,778 | -9,739 | -9,361 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1,806 | -1,760 | -1,800 | -1,790 | -2,029 | -2,179 | -1,947 | -2,007 | -1,917 | -1,881 | -2,051 | -1,902 | |||||
Stockholders Equity | -2,059 | -554 | 356 | -764 | -1,183 | -322 | -1,174 | -227 | -174 | -1,022 | -235 | 271 | |||||
Minority Interest | 977 | 931 | 921 | 911 | 943 | 957 | 932 | 948 | 941 | 940 | 945 | 934 | |||||
Liabilities And Stockholders Equity | 24,498 | 26,366 | 26,824 | 27,266 | 26,421 | 26,523 | 26,540 | 26,495 | 26,913 | 27,350 | 27,064 | 25,503 | |||||
Common Stock Shares Issued | 373 | 371 | 370 | 370 | 370 | 368 | 368 | 367 | 367 | 365 | 365 | 364 | |||||
Shares Outstanding | 373 | 371 | 370 | 370 | 370 | 368 | 368 | 367 | 367 | 365 | 365 | 364 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.37% | -16.61% | -15.56% | - | - | - | - | - | - | - | - | - |
| 2025 | -16.04% | 16.60% | 19.06% | 27.16% | 14.26% | 2.72% | -8.77% | 4.08% | 5.60% | -16.36% | -5.56% | -3.04% |
| 2024 | -21.38% | -15.95% | -6.06% | -3.77% | 31.64% | 33.77% | -13.37% | -18.80% | -19.13% | -0.42% | -39.83% | -36.07% |
| 2023 | 38.20% | 22.07% | 62.82% | -12.43% | -12.65% | -22.21% | -5.59% | 1.50% | 11.04% | -1.08% | -5.81% | -26.02% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.32 | 1.47 | 1.30 | 1.31 | 1.35 | 0.86 | 1.19 | 1.19 | 1.22 | 1.30 | 1.20 | 1.12 | |||||
| Quick Ratio | 0.77 | 0.88 | 0.78 | 0.79 | 0.76 | 0.49 | 0.63 | 0.62 | 0.64 | 0.69 | 0.65 | 0.59 | |||||
| Working Capital | 1.45B | 1.98B | 1.46B | 1.54B | 1.48B | -978.00M | 845.00M | 842.00M | 991.00M | 1.29B | 824.00M | 494.00M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -12.42 | 68.94 | 74.35 | -35.50 | -22.54 | -83.37 | -22.81 | -117.72 | -155.67 | -334.54 | -116.17 | 93.11 | |||||
| Interest Coverage TTM | 0.35 | 1.13 | 1.23 | 1.08 | 1.13 | 1.11 | 0.95 | 0.74 | 0.78 | 0.73 | 0.29 | 0.45 | |||||
| Debt Ratio | 1.04 | 0.99 | 0.99 | 0.99 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.00 | 1.01 | 0.99 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.41 | 0.39 | 0.38 | 0.37 | 0.36 | 0.36 | 0.35 | 0.35 | 0.34 | 0.33 | 0.32 | 0.31 | |||||
| Days Sales Outstanding TTM | 73.88 | 79.84 | 82.09 | 79.83 | 77.27 | 78.46 | 77.86 | 76.26 | 76.05 | 78.94 | 78.77 | 74.05 | |||||
| Receivables Turnover TTM | 4.94 | 4.57 | 4.45 | 4.57 | 4.72 | 4.65 | 4.69 | 4.79 | 4.80 | 4.62 | 4.63 | 4.93 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -3.24 | 0.42 | 1.00 | 0.29 | -0.11 | -0.13 | -0.53 | -1.33 | -1.27 | -1.67 | -2.66 | -0.51 | |||||
| Free Cash Flow Per Share TTM | 2.76 | 2.70 | 2.95 | 3.01 | 3.32 | 3.42 | 2.87 | 2.62 | 2.29 | 2.24 | 2.56 | -1.71 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 71.64% | 71.27% | 71.31% | 71.35% | 71.39% | 71.65% | 71.36% | 71.28% | 71.28% | 71.23% | 71.17% | 70.97% | |||||
| Operating Profit Margin TTM | 5.57% | 17.66% | 18.92% | 16.19% | 15.84% | 16.06% | 14.25% | 11.37% | 11.92% | 11.00% | 4.27% | 7.13% | |||||
| Net Profit Margin TTM | -11.47% | 1.53% | 3.74% | 1.11% | -0.41% | -0.48% | -2.07% | -5.36% | -5.20% | -6.98% | -11.38% | -2.24% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 8.22% | 6.66% | 5.86% | 7.13% | 8.53% | 9.91% | 10.91% | 10.20% | 10.01% | 7.79% | 5.11% | 1.93% | |||||
| Net Income Growth (1Y) | 2,920.00% | -441.30% | -291.33% | -122.11% | -91.42% | -92.47% | -79.84% | 163.64% | 32.39% | 188.21% | -476.74% | -506.52% | |||||
| EPS Growth (1Y) | 2,894.08% | -438.64% | -289.83% | -121.93% | -91.48% | -92.53% | -80.00% | 161.41% | 31.12% | 185.92% | -473.75% | -503.62% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1.67 | 16.42 | 6.39 | 22.66 | -59.78 | -64.48 | -15.34 | -5.20 | -8.35 | -4.79 | -3.09 | -15.61 | |||||
| P/B TTM | -0.98 | 6.84 | 6.73 | -3.23 | -2.02 | -9.21 | -2.56 | -11.30 | -22.37 | -35.69 | -12.78 | 10.77 | |||||
| P/S TTM | 0.19 | 0.25 | 0.24 | 0.25 | 0.25 | 0.31 | 0.32 | 0.28 | 0.43 | 0.33 | 0.35 | 0.35 | |||||
| Market Cap | 2.01B | 2.58B | 2.39B | 2.47B | 2.39B | 2.97B | 3.01B | 2.56B | 3.89B | 2.93B | 3.00B | 2.92B | |||||
| Enterprise Value | 21.48B | 22.07B | 22.10B | 22.48B | 22.77B | 23.40B | 23.76B | 23.60B | 25.21B | 24.37B | 24.65B | 22.89B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 1.03B | 1.00B | 1.10B | 1.12B | 1.23B | 1.26B | 1.06B | 963.00M | 839.00M | 817.00M | 934.00M | -623.00M | |||||
| Net Debt | 19.47B | 19.49B | 19.70B | 20.01B | 20.38B | 20.44B | 20.76B | 21.04B | 21.32B | 21.44B | 21.65B | 19.97B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2026-05-19Sale
Owner: Lee, Frank D.
Title: -
Shares: 24,456
Price/Share: $5.43
Value: $132,796.08
Shares Owned: 49,339
Relationship: Director
Ownership: Direct
2026-03-03Sale
Owner: Carson, Seana
Title: EVP, General Counsel
Shares: 4,420
Price/Share: $5.77
Value: $25,503.40
Shares Owned: 616,761
Relationship: Officer
Ownership: Direct
2026-02-27Sale
Owner: Carson, Seana
Title: EVP, General Counsel
Shares: 8,388
Price/Share: $5.95
Value: $49,908.60
Shares Owned: 809,258
Relationship: Officer
Ownership: Direct
2025-11-25Purchase
Owner: Paulson, & Co. Inc.
Title: -
Shares: 2,500,000
Price/Share: $6.25
Value: $15,625,000.00
Shares Owned: 73,255,869
Relationship: TenPercentOwner
Ownership: Indirect
2025-09-08Sale
Owner: Carson, Seana
Title: EVP, General Counsel
Shares: 13,370
Price/Share: $7.31
Value: $97,734.70
Shares Owned: 499,585
Relationship: Officer
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
60.82%
Inst. Shares: 226,741,488
Shares Outstanding: 372,800,000
2025-12-31
62.69%
Inst. Shares: 232,531,890
Shares Outstanding: 370,900,000
2025-09-30
63.56%
Inst. Shares: 235,997,010
Shares Outstanding: 371,300,000
2025-06-30
68.46%
Inst. Shares: 253,917,480
Shares Outstanding: 370,900,000
2025-03-31
62.90%
Inst. Shares: 232,469,253
Shares Outstanding: 369,600,000
Bausch Health Companies Inc. (BHC) — SEC Financial Statements & Analysis
Bausch Health Companies Inc. (BHC) is a pharmaceutical preparations company, incorporated in NJ. Bausch Health Companies Inc. trades on NYSE as: BHC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Bausch Health Companies Inc. reported a 8.22% year-over-year revenue growth, a Gross Profit Margin of 71.64% (TTM), a Debt-to-Equity ratio of -12.42x, a Price-to-Sales (P/S) ratio of 0.19x (TTM), a Price-to-Book (P/B) ratio of -0.98 (TTM), at a market cap of $2.01B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 8.22%
- Gross Profit Margin TTM
- 71.64%
- Debt To Equity
- -12.42x
- P/S TTM
- 0.19x
- P/B TTM
- -0.98
- Market Cap
- $2.01B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Bausch Health Companies Inc. in?
Bausch Health Companies Inc. (BHC) operates in the Pharmaceutical Preparations industry.
What is BHC's market cap?
Bausch Health Companies Inc. (BHC) has a market capitalization of $2.01B as of 2026-03-31.
What exchange does BHC trade on?
Bausch Health Companies Inc. (BHC) trades on the NYSE.
Where is Bausch Health Companies Inc. incorporated?
Bausch Health Companies Inc. is incorporated in NJ.